AIMT - Aimmune Therapeutics EPS beats by $0.03 July, 30 2020 04:12 PM Aimmune Therapeutics Inc. Aimmune Therapeutics (NASDAQ:AIMT): Q2 Non-GAAP EPS of -$0.81; GAAP EPS of -$1.06 beats by $0.03.More news on: Aimmune Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...